Silong Hu

1 article listing Silong Hu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial Nature Communications